nature medicine glp-1 Unlocking the broad health benefits and risks of receptor agonist drugs Study identifies benefits, risks linked

For patients who have undergone radioactive iodine ablation or thyroidectomy and are on levothyroxine replacement, more frequent monitoring (every 6-12 weeks) is advisable during active weight loss, with annual testing once stable

According to Honigber and colleagues, semaglutide and dulaglutide received the same indication in 2020

Long-Term Efficacy: WW Med+ members prescribed GLP-1s reached a 21% average weight loss at 12 months

What is the risk (medications, sensitive digestion, chronic disease)

Similarly, there are reports of patients with psoriasis and metabolic syndrome being treated with GLP-1 receptor agonists in clinical practice, with some suggesting potential improvements in inflammatory markers, though causality cannot be established from these observations

The persulfidation reaction was performed in 100 mM sodium phosphate buffer (pH 7.4) containing 10 M enzyme and 300 M cysteine persulfide